Article Details
Retrieved on: 2024-11-06 21:08:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
If one includes royalty revenue generated on Roche's ex-US sales of ELEVIDYS, total ELEVIDYS performance was $190.5 million for the quarter. Likewise, ...
Article found on: investorrelations.sarepta.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here